MattenPlant announced the launch of its Pharmaceutical Water for Injection (Cold WFI) initiative, bringing Southeast Asia’s first membrane technology-based Cold WFI system to market. Pharmaceutical manufacturers, engineering consultants and industry stakeholders were invited to learn more at Matten's Booth B2-D20 at the Singapore International Water Week 2026 (SIWW 2026). The launch marked Matten’s strategic expansion into pharmaceutical water systems, building on its established track record of serving the food and beverage and pharmaceutical sectors, where hygienic system design and Good Manufacturing Practice compliance are baseline requirements. It comes as pharmaceutical manufacturing investments continue to grow across Southeast Asia, driving demand for compliant water infrastructure that can be deployed, serviced and upgraded closer to the point of use. The initiative enables pharmaceutical manufacturers to access locally assembled Cold WFI systems backed by regional engineering and service support.